These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1806247)

  • 1. Trivalent chromium, in atherosclerosis and diabetes.
    Mossop RT
    Cent Afr J Med; 1991 Nov; 37(11):369-74. PubMed ID: 1806247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromium metabolism and its role in disease processes in man.
    Anderson RA
    Clin Physiol Biochem; 1986; 4(1):31-41. PubMed ID: 3514054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in selected serum parameters of broiler chicken fed supplemental chromium.
    Króliczewska B; Zawadzki W; Dobrzanski Z; Kaczmarek-Oliwa A
    J Anim Physiol Anim Nutr (Berl); 2004 Dec; 88(11-12):393-400. PubMed ID: 15584948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats.
    Lai MH; Chen YY; Cheng HH
    Int J Vitam Nutr Res; 2006 Nov; 76(6):391-7. PubMed ID: 17607959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes.
    Trow LG; Lewis J; Greenwood RH; Sampson MJ; Self KA; Crews HM; Fairweather-Tait SJ
    Int J Vitam Nutr Res; 2000 Jan; 70(1):14-8. PubMed ID: 10683756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated ldl cholesterol or by decreased hdl cholesterol?: response to Drexel et al.
    Schulze MB; Hoffmann K
    Diabetes Care; 2005 May; 28(5):1264; author reply 1264-5. PubMed ID: 15855613
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum lipids and apolipoproteins in relation to glycaemic control and diabetic nephropathy in long-term survivors of diabetes: results of the Erfurt Study.
    Schauer UJ; Pissarek D; Lundershausen R; Rühling K; Winkler L; Panzram G
    Exp Clin Endocrinol; 1988 Mar; 92(3):280-6. PubMed ID: 3267003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients.
    Rabinovitz H; Friedensohn A; Leibovitz A; Gabay G; Rocas C; Habot B
    Int J Vitam Nutr Res; 2004 May; 74(3):178-82. PubMed ID: 15296075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid risk factors in patients requiring arterial reconstruction.
    Seeger JM; Silverman SH; Flynn TC; Bailey JC; Klingman NV; Lawson GA; Borgeson MD; Barratt EJ
    J Vasc Surg; 1989 Oct; 10(4):418-24. PubMed ID: 2795767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of chromium in cell biology and medicine].
    Terpiłowska S; Zaporowska H
    Przegl Lek; 2004; 61 Suppl 3():51-4. PubMed ID: 15682944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma trivalent chromium, glucose tolerance and insulin secretion in juvenile- and adult-onset diabetes mellitus.
    Gedik O; Unal S; Koray Z
    Isr J Med Sci; 1980 Aug; 16(8):563-5. PubMed ID: 6998922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chromium supplementation on glucose tolerance and lipid profile.
    Bahijri SM
    Saudi Med J; 2000 Jan; 21(1):45-50. PubMed ID: 11533750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromium and atherosclerosis].
    Canonaco F; Bertolani P; Cucchi C
    Pediatr Med Chir; 1986; 8(3):415-6. PubMed ID: 3537981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of HDL cholesterol in diabetes mellitus in relation to various types of therapy].
    Floriani M; Spadoni M
    Quad Sclavo Diagn; 1984 Jun; 20(2):236-43. PubMed ID: 6396678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics.
    Mossop RT
    Cent Afr J Med; 1983 Apr; 29(4):80-2. PubMed ID: 6883494
    [No Abstract]   [Full Text] [Related]  

  • 18. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial.
    Geohas J; Daly A; Juturu V; Finch M; Komorowski JR
    Am J Med Sci; 2007 Mar; 333(3):145-53. PubMed ID: 17496732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic symptoms due to possible chromium deficiency in long-term parenteral nutrition that closely mimic metronidazole-induced syndromes.
    Verhage AH; Cheong WK; Jeejeebhoy KN
    JPEN J Parenter Enteral Nutr; 1996; 20(2):123-7. PubMed ID: 8676530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.